Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral montelukast for hospitalized acute asthma exacerbation
ACTRN12612000816853Phase 3Completed
- Sponsor
- Hilton Pharma
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma and acute severe asthma comparing Montelukast + standard therapy with Placebo + standard therapy (2 arms). Primary endpoints: Improvement in FEV1 and Improvement in PEFR. Started Feb 2005; status: completed.
02
Drugs
montelukast
03
Conditions
asthmaacute severe asthma
Beyond the preview
Go deeper on ACTRN12612000816853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000816853.